Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
David P Hochman is See Remarks at Orchestra Biomed Holdings. OQRO lists 20 transactions filed with the SEC under this name, the latest on Nov 9, 2026, each linked to the official Form 4.
See Remarks
Disclosures on record
20
Companies involved
1
8 buys, median +17.6 pts vs S&P 500, beat it 5 of 8 times.
Average +15.5 pts vs S&P 500. Each buy is one disclosure of open-market purchases in one company on one filing date, filed Dec 19, 2024 to Jun 2, 2026, measured from the first close after the filing. Past results, not a forecast.
10 purchases disclosed; 63% of the 8 measured at 90 days finished ahead of the index. $1,000 placed after each of the 6 purchases disclosed since 2025-11-14 would be worth $9.6K today ($6K put in); the same in the S&P 500 (SPY): $6.3K.
Not ranked: fewer than 10 purchases measured at 90 days. The middle of the 82 ranked insiders is −5.5 pts (median, against the S&P 500).
Orchestra Biomed HoldingsOBIO
20 disclosures · Dec 2024 – Nov 2026 · 10 bought
Nov 9, 2026Bought~$25K
DetailsOfficial recordSep 10, 20263,283disclosed Sep 11
DetailsOfficial recordEqual weight counts every purchase once; by size counts it for its disclosed dollars. Both are measured from the first close after it was reported. Past results describe the past, not a forecast. How this is measured · Leaderboard
Sep 10, 20263,283disclosed Sep 11
DetailsOfficial recordSep 3, 2026Bought~$48Kdisclosed Sep 8
DetailsOfficial recordJun 10, 20263,283disclosed Jun 12
DetailsOfficial recordJun 10, 20263,283disclosed Jun 12
DetailsOfficial recordJun 1, 2026Bought~$19Kdisclosed Jun 2
DetailsOfficial recordMay 15, 2026Bought~$19Kdisclosed May 19
DetailsOfficial recordMar 25, 202632Kdisclosed Mar 27
DetailsOfficial recordMar 13, 2026Bought~$43Kdisclosed Mar 16
DetailsOfficial recordFeb 12, 2026504Kdisclosed Feb 13
DetailsOfficial recordDec 10, 202540Kdisclosed Dec 12
DetailsOfficial recordDec 10, 20253,283disclosed Dec 12
DetailsOfficial recordNov 14, 2025Bought~$20Kdisclosed Nov 17
DetailsOfficial recordNov 13, 20253,283disclosed Nov 14
DetailsOfficial recordNov 13, 20253,283disclosed Nov 14
DetailsOfficial recordAug 21, 2025Bought~$15Kdisclosed Aug 25
DetailsOfficial recordAug 4, 2025Bought~$55K
DetailsOfficial recordDec 23, 2024Bought~$19Kdisclosed Dec 26
DetailsOfficial recordDec 18, 2024Bought~$25Kdisclosed Dec 19
DetailsOfficial recordAs of the latest filing on , David P Hochman reported holding 1,505,379 shares of Orchestra Biomed Holdings (OBIO), worth about $10.9M at the last close of $7 (Nov 13, 2026): 1,067,463 held directly and 437,916 through a dph 2008 trust. In the last 12 months, David P Hochman bought $174K in 6 open-market purchases.
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Orchestra Biomed Holdings OBIO | 1,505,379 | 1.07M direct · 438K dph 2008 trust | $7 | $10.9M | Nov 9, 2026 |
Is this David P Hochman’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
David P Hochman bought shares on the open market in 9 different years since 2014 across 2 companies.
David P Hochman reported 35 open-market purchases and 0 sales since 2014; purchases in 9 different years, most recently 2026.
| Year | Bought | Sold |
|---|---|---|
| 2026 | $154K5×5 trades | — |
| 2025 | $90K3×3 trades | — |
| 2024 | $138K11×11 trades | — |
| 2019 | $14K1×1 trade | — |
| 2018 | $61K2×2 trades | — |
| 2017 | $159K4×4 trades | — |
| 2016 | $77K2×2 trades | — |
| 2015 | $1.9K1×1 trade | — |
| 2014 | $15K6×6 trades | — |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
On the latest SEC Form 4, dated Nov 9, 2026, David P Hochman reported holding 1,505,379 shares of Orchestra Biomed Holdings (OBIO), of which 437,916 are held indirectly. At the last close of $7 on Nov 13, 2026, that is about $10.9M. This is the stake disclosed in filings, not a net worth.
In SEC filings of the last 12 months, David P Hochman reported 6 open-market purchases worth $174K, and no open-market sale. Shares withheld for taxes, gifts and option exercises are not counted in these totals.
David P Hochman bought shares on the open market in 9 different years since 2014 across 2 companies.
In SEC filings since 2014: the latest open-market purchase is from 2026; no open-market sale is on record.
2 companies: Orchestra Biomed Holdings (OBIO, 2024–2026), Corbus Pharmaceuticals Holdings (CRBP, 2014–2019).
David P Hochman reported 19 open-market purchases and 0 sales here, 2024 to 2026.
David P Hochman reported 16 open-market purchases and 0 sales here, 2014 to 2019.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
